Papers/PMID:19838489
Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.
Arquivos brasileiros de cardiologia2009The record
3 findings · 1 compound · 3 endpoints · 2 null
What it reported
How to read these marksWhat moved
1 finding
Camellia sinensis — decreases LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Mean lipid variations induced by the use of green tea (Camellia sinensis) showed a 3.9% reduction (p = 0.006) in total cholesterol concentrations and a 4.5% reduction (p = 0.026) in LDL-cholesterol.”
Quoted verbatim from Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.. - Study
- crossover
- Duration
- 8 weeks
- Dose
- 250-mg green tea dry extract capsules
- Population
- Adults aged 21-71 with dyslipidemias; low-fat background diet; crossover design
Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.2009PMID:19838489Permalink
What did not
2 findings
Camellia sinensis — no detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The intake of green tea did not significantly influence HDL-cholesterol, triglyceride, and Apo-B levels.”
Quoted verbatim from Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.. - Study
- crossover
- Duration
- 8 weeks
- Dose
- 250-mg green tea dry extract capsules
- Population
- Adults aged 21-71 with dyslipidemias; low-fat background diet; crossover design
Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.2009PMID:19838489Permalink
Camellia sinensis — no detected effect on triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The intake of green tea did not significantly influence HDL-cholesterol, triglyceride, and Apo-B levels.”
Quoted verbatim from Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.. - Study
- crossover
- Duration
- 8 weeks
- Dose
- 250-mg green tea dry extract capsules
- Population
- Adults aged 21-71 with dyslipidemias; low-fat background diet; crossover design
Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias.2009PMID:19838489Permalink